Australia markets close in 5 hours 43 minutes

Inovio Pharmaceuticals, Inc. (INO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
12.79-0.28 (-2.14%)
At close: 04:00PM EDT
12.80 +0.01 (+0.08%)
After hours: 07:55PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 338.60M
Enterprise value 223.52M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)348.32
Price/book (mrq)2.89
Enterprise value/revenue 268.64
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 367.56%
S&P500 52-week change 326.44%
52-week high 314.75
52-week low 33.84
50-day moving average 311.28
200-day moving average 37.16

Share statistics

Avg vol (3-month) 3445.47k
Avg vol (10-day) 3313.29k
Shares outstanding 525.91M
Implied shares outstanding 625.91M
Float 825.53M
% held by insiders 11.47%
% held by institutions 117.63%
Shares short (30 Apr 2024) 42.03M
Short ratio (30 Apr 2024) 45.6
Short % of float (30 Apr 2024) 47.89%
Short % of shares outstanding (30 Apr 2024) 47.83%
Shares short (prior month 28 Mar 2024) 42.1M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 325 Jan 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-16,868.64%

Management effectiveness

Return on assets (ttm)-38.21%
Return on equity (ttm)-85.09%

Income statement

Revenue (ttm)717.07k
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -118.56M
Net income avi to common (ttm)-124.94M
Diluted EPS (ttm)-6.09
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)105.61M
Total cash per share (mrq)4.08
Total debt (mrq)13.43M
Total debt/equity (mrq)14.22%
Current ratio (mrq)4.77
Book value per share (mrq)3.64

Cash flow statement

Operating cash flow (ttm)-116.46M
Levered free cash flow (ttm)-73.01M